Stay updated with breaking news from Cell Stem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
According to a recent study published in Cell Stem Cell, researchers have found that the Parkinson’s disease drug ropinirole may be effective in slowing
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles. There is no cure, and current treatments focus on reducing symptoms and providing supportive care. Reporting June 1 in the journal Cell Stem Cell, researchers from Japan show in an early clinical trial that the Parkinson’s disease drug ropinirole is safe to use in ALS patients and delayed disease progression by 27.9 weeks on average.
Yale researchers investigate a multi-tasking protein, find a new way to study a key area of the brain, and earn honors for innovative applied mathematics.
Amyotrophic lateral sclerosis is an incurable disease that causes people to gradually lose control of their muscles.
Results from a small clinical trial show that the Parkinson’s disease drug ropinirole delayed the progression of amyotrophic lateral sclerosis (ALS) by an average of 27.9 weeks.